Jason Dinges is an experienced investment professional and IP counsel at Morningside Technology Advisory LLC, where they focus on early-stage biotech venture capital investments. They have served as a board member for multiple biotech companies, including CellCentric, Alentis Therapeutics, and Prilenia. Jason holds a B.S. from Illinois Wesleyan University, a Ph.D. from Iowa State University, and a J.D. from the University of Iowa College of Law. They have been involved in advancing innovative therapeutics through their work in the industry since 2011.
This person is not in the org chart
This person is not in any teams
This person is not in any offices